Tuesday, July 18, 2017

FDA approves Vosevi for Hepatitis C - FDA Press Releases

The U.S. Food and Drug Administration today approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis.

from Food and Drug Administration--Press Releases http://ift.tt/2vfxQGe
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)